The Measurement of Handicap in Dermatology:

Key References


Finlay A Y. Quality of Life Measurement in Dermatology: a practical guide. Br J Dermatol 1997; 136: 305-314

Finlay AY. Quality of life assessments in dermatology. Seminars in Cutaneous Medicine and Surgery, 1998; 17: 291-296.

DLQI Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol, 1994; 19: 210-216.

Lewis V L, Finlay A Y. Ten years experience of the Dermatology Life Quality Index (DLQI) J Investig Dermatol Symp Proc, 2004; 9(2):169-180.

Hongbo Y, Thomas C L, Harrison M A, Salek M S, Finlay A Y. Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean? J Invest Dermatol, 2005; 125: 659-664.

CDLQI Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol, 1995; 132: 942-949.

Holme S A, Mann I, Sharpe J L, Dykes P J, Lewis-Jones M S, Finlay A Y. The Childrens' Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285-290.

PDI Finlay AY, Kelly SE. Psoriasis - an index of disability. Clinical and Experimental Dermatology, 1987; l2: 8-ll.

Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol, 1995; 132: 236-244.

Lewis VJ, Finlay AY. Two Decades Experience of the Psoriasis Disability Index. Dermatology, 2005; 210: 261-268.

DFI Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol, 1998; 138: 107-113.

IDQOL Lewis-Jones M S, Finlay A Y, Dykes P J. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001 144: 104-10

CADI Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clinical and Experimental Dermatology, 1992; 17: 1-3

FDLQI Basra MKA, Sue-Ho R, Finlay A Y. Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-538